Tenax Therapeutics CEO Christopher Giordano's 2022 pay falls 22% to $667K
Tenax Therapeutics reports 2022 executive compensation
By ExecPay News
Published: April 28, 2023
Tenax Therapeutics reported fiscal year 2022 executive compensation information on April 28, 2023.
In 2022, three executives at Tenax Therapeutics received on average a compensation package of $452K, a 40% decrease compared to previous year.
Average pay of disclosed executives at Tenax Therapeutics
Christopher T. Giordano, Chief Executive Officer, received $667K in total, which decreased by 22% compared to 2021. 58% of Giordano's compensation, or $386K, was in salary. Giordano also received $145K in non-equity incentive plan, $104K in option awards, as well as $32K in other compensation.
Stuart Rich, Chief Medical Officer, received a compensation package of $468K, which decreased by 43% compared to previous year. 66% of the compensation package, or $309K, was in salary.
Eliot M. Lurier, Chief Financial Officer, earned $222K in 2022, a 756% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 28, 2023.